Casini, R.; Vyhlidal, C.A.; Bracken, J.M.; Sherman, A.K.; Ahmed, A.; Singh, V.; Williams, V.; Shakhnovich, V.
Impact of Duodenal Pathology on Oral Drug Bioavailability and Disease Outcomes in Pediatric Crohn’s Disease. Pharmaceuticals 2023, 16, 373.
https://doi.org/10.3390/ph16030373
AMA Style
Casini R, Vyhlidal CA, Bracken JM, Sherman AK, Ahmed A, Singh V, Williams V, Shakhnovich V.
Impact of Duodenal Pathology on Oral Drug Bioavailability and Disease Outcomes in Pediatric Crohn’s Disease. Pharmaceuticals. 2023; 16(3):373.
https://doi.org/10.3390/ph16030373
Chicago/Turabian Style
Casini, Rebecca, Carrie A. Vyhlidal, Julia M. Bracken, Ashley K. Sherman, Atif Ahmed, Vivekanand Singh, Veronica Williams, and Valentina Shakhnovich.
2023. "Impact of Duodenal Pathology on Oral Drug Bioavailability and Disease Outcomes in Pediatric Crohn’s Disease" Pharmaceuticals 16, no. 3: 373.
https://doi.org/10.3390/ph16030373
APA Style
Casini, R., Vyhlidal, C. A., Bracken, J. M., Sherman, A. K., Ahmed, A., Singh, V., Williams, V., & Shakhnovich, V.
(2023). Impact of Duodenal Pathology on Oral Drug Bioavailability and Disease Outcomes in Pediatric Crohn’s Disease. Pharmaceuticals, 16(3), 373.
https://doi.org/10.3390/ph16030373